Report Detail

Request for Sample of this report

Pharma & Healthcare Global Low Molecular Weight Heparin API Supply, Demand and Key Producers, 2026-2032

  • RnM4663845
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

The global Low Molecular Weight Heparin API market size is expected to reach $ 1518 million by 2032, rising at a market growth of 7.8% CAGR during the forecast period (2026-2032).
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the low molecular weight heparin API.
The Low Molecular Weight Heparin (LMWH) API market plays a crucial role in the global pharmaceutical industry due to the widespread use of LMWHs in the prevention and treatment of blood clot-related disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). LMWH APIs are preferred in clinical settings for their favorable pharmacological properties, including better bioavailability, longer half-life, and reduced risk of side effects compared to unfractionated heparin. The increasing prevalence of cardiovascular diseases and venous thromboembolism, aging populations, and a rise in surgical procedures worldwide have significantly driven demand for LMWH-based therapies.
The North American and European markets lead in demand due to a high prevalence of thrombosis-related conditions and advanced healthcare infrastructure. Asia-Pacific is emerging as a growth market, driven by increased healthcare spending and the rise of generics.
Low Molecular Weight Heparin API segment market, the Enoxaparin Sodium holds an important share, and it is expected to reach a value of US$ 1,258.82 million by 2030, at a CAGR of 12.46% during 2024 and 2030.
The global key companies of Low Molecular Weight Heparin API include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Changzhou Qianhong Biopharma, and Qingdao Jiulong Biopharmaceutical, etc. In 2023, the global five largest players hold a share approximately 72.91% in terms of revenue.
This report studies the global Low Molecular Weight Heparin API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Low Molecular Weight Heparin API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Low Molecular Weight Heparin API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Low Molecular Weight Heparin API total production and demand, 2021-2032, (Billion Units)
Global Low Molecular Weight Heparin API total production value, 2021-2032, (USD Million)
Global Low Molecular Weight Heparin API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Billion Units), (based on production site)
Global Low Molecular Weight Heparin API consumption by region & country, CAGR, 2021-2032 & (Billion Units)
U.S. VS China: Low Molecular Weight Heparin API domestic production, consumption, key domestic manufacturers and share
Global Low Molecular Weight Heparin API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Billion Units)
Global Low Molecular Weight Heparin API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Billion Units)
Global Low Molecular Weight Heparin API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Billion Units)
This report profiles key players in the global Low Molecular Weight Heparin API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yantai Dongcheng Pharmaceutical, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend, Changzhou Qianhong Biopharma, Qingdao Jiulong Biopharmaceutical, Dongying Tiandong Pharmaceutical, Yino Pharma, Opocrin, Hebei Changshan, Hubei Enoray Biopharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Low Molecular Weight Heparin API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Billion Units) and average price (US$/Billion Untis) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Low Molecular Weight Heparin API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Low Molecular Weight Heparin API Market, Segmentation by Type:
Low Molecular Weight Heparin Sodium
Low Molecular Weight Heparin Calcium
Global Low Molecular Weight Heparin API Market, Segmentation by Application:
Enoxaparin Sodium
Nadroparin Calcium
Dalteparin Sodium
Tinzaparin Sodium
Parnaparin Sodium
Companies Profiled:
Yantai Dongcheng Pharmaceutical
Shenzhen Hepalink Pharmaceutical
Nanjing King-friend
Changzhou Qianhong Biopharma
Qingdao Jiulong Biopharmaceutical
Dongying Tiandong Pharmaceutical
Yino Pharma
Opocrin
Hebei Changshan
Hubei Enoray Biopharmaceutical
Nanjing Nanda Pharmaceutical
Cisen Pharmaceutical
Key Questions Answered:
1. How big is the global Low Molecular Weight Heparin API market?
2. What is the demand of the global Low Molecular Weight Heparin API market?
3. What is the year over year growth of the global Low Molecular Weight Heparin API market?
4. What is the production and production value of the global Low Molecular Weight Heparin API market?
5. Who are the key producers in the global Low Molecular Weight Heparin API market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Low Molecular Weight Heparin API Introduction
  • 1.2 World Low Molecular Weight Heparin API Supply & Forecast
    • 1.2.1 World Low Molecular Weight Heparin API Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Low Molecular Weight Heparin API Production (2021-2032)
    • 1.2.3 World Low Molecular Weight Heparin API Pricing Trends (2021-2032)
  • 1.3 World Low Molecular Weight Heparin API Production by Region (Based on Production Site)
    • 1.3.1 World Low Molecular Weight Heparin API Production Value by Region (2021-2032)
    • 1.3.2 World Low Molecular Weight Heparin API Production by Region (2021-2032)
    • 1.3.3 World Low Molecular Weight Heparin API Average Price by Region (2021-2032)
    • 1.3.4 Europe Low Molecular Weight Heparin API Production (2021-2032)
    • 1.3.5 China Low Molecular Weight Heparin API Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Low Molecular Weight Heparin API Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Low Molecular Weight Heparin API Major Market Trends

2 Demand Summary

  • 2.1 World Low Molecular Weight Heparin API Demand (2021-2032)
  • 2.2 World Low Molecular Weight Heparin API Consumption by Region
    • 2.2.1 World Low Molecular Weight Heparin API Consumption by Region (2021-2026)
    • 2.2.2 World Low Molecular Weight Heparin API Consumption Forecast by Region (2027-2032)
  • 2.3 United States Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.4 China Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.5 Europe Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.6 Japan Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.7 South Korea Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.8 ASEAN Low Molecular Weight Heparin API Consumption (2021-2032)
  • 2.9 India Low Molecular Weight Heparin API Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Low Molecular Weight Heparin API Production Value by Manufacturer (2021-2026)
  • 3.2 World Low Molecular Weight Heparin API Production by Manufacturer (2021-2026)
  • 3.3 World Low Molecular Weight Heparin API Average Price by Manufacturer (2021-2026)
  • 3.4 Low Molecular Weight Heparin API Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Low Molecular Weight Heparin API Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Low Molecular Weight Heparin API in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Low Molecular Weight Heparin API in 2025
  • 3.6 Low Molecular Weight Heparin API Market: Overall Company Footprint Analysis
    • 3.6.1 Low Molecular Weight Heparin API Market: Region Footprint
    • 3.6.2 Low Molecular Weight Heparin API Market: Company Product Type Footprint
    • 3.6.3 Low Molecular Weight Heparin API Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Low Molecular Weight Heparin API Production Value Comparison
    • 4.1.1 United States VS China: Low Molecular Weight Heparin API Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Low Molecular Weight Heparin API Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Low Molecular Weight Heparin API Production Comparison
    • 4.2.1 United States VS China: Low Molecular Weight Heparin API Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Low Molecular Weight Heparin API Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Low Molecular Weight Heparin API Consumption Comparison
    • 4.3.1 United States VS China: Low Molecular Weight Heparin API Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Low Molecular Weight Heparin API Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Low Molecular Weight Heparin API Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Low Molecular Weight Heparin API Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Low Molecular Weight Heparin API Production (2021-2026)
  • 4.5 China Based Low Molecular Weight Heparin API Manufacturers and Market Share
    • 4.5.1 China Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Low Molecular Weight Heparin API Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Low Molecular Weight Heparin API Production (2021-2026)
  • 4.6 Rest of World Based Low Molecular Weight Heparin API Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Low Molecular Weight Heparin API Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Low Molecular Weight Heparin API Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Low Molecular Weight Heparin API Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Low Molecular Weight Heparin API Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Low Molecular Weight Heparin Sodium
    • 5.2.2 Low Molecular Weight Heparin Calcium
  • 5.3 Market Segment by Type
    • 5.3.1 World Low Molecular Weight Heparin API Production by Type (2021-2032)
    • 5.3.2 World Low Molecular Weight Heparin API Production Value by Type (2021-2032)
    • 5.3.3 World Low Molecular Weight Heparin API Average Price by Type (2021-2032)

6 Market Analysis by Application

  • 6.1 World Low Molecular Weight Heparin API Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Enoxaparin Sodium
    • 6.2.2 Nadroparin Calcium
    • 6.2.3 Dalteparin Sodium
    • 6.2.4 Tinzaparin Sodium
    • 6.2.5 Parnaparin Sodium
  • 6.3 Market Segment by Application
    • 6.3.1 World Low Molecular Weight Heparin API Production by Application (2021-2032)
    • 6.3.2 World Low Molecular Weight Heparin API Production Value by Application (2021-2032)
    • 6.3.3 World Low Molecular Weight Heparin API Average Price by Application (2021-2032)

7 Company Profiles

  • 7.1 Yantai Dongcheng Pharmaceutical
    • 7.1.1 Yantai Dongcheng Pharmaceutical Details
    • 7.1.2 Yantai Dongcheng Pharmaceutical Major Business
    • 7.1.3 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.1.4 Yantai Dongcheng Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
    • 7.1.6 Yantai Dongcheng Pharmaceutical Competitive Strengths & Weaknesses
  • 7.2 Shenzhen Hepalink Pharmaceutical
    • 7.2.1 Shenzhen Hepalink Pharmaceutical Details
    • 7.2.2 Shenzhen Hepalink Pharmaceutical Major Business
    • 7.2.3 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.2.4 Shenzhen Hepalink Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
    • 7.2.6 Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
  • 7.3 Nanjing King-friend
    • 7.3.1 Nanjing King-friend Details
    • 7.3.2 Nanjing King-friend Major Business
    • 7.3.3 Nanjing King-friend Low Molecular Weight Heparin API Product and Services
    • 7.3.4 Nanjing King-friend Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Nanjing King-friend Recent Developments/Updates
    • 7.3.6 Nanjing King-friend Competitive Strengths & Weaknesses
  • 7.4 Changzhou Qianhong Biopharma
    • 7.4.1 Changzhou Qianhong Biopharma Details
    • 7.4.2 Changzhou Qianhong Biopharma Major Business
    • 7.4.3 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Product and Services
    • 7.4.4 Changzhou Qianhong Biopharma Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Changzhou Qianhong Biopharma Recent Developments/Updates
    • 7.4.6 Changzhou Qianhong Biopharma Competitive Strengths & Weaknesses
  • 7.5 Qingdao Jiulong Biopharmaceutical
    • 7.5.1 Qingdao Jiulong Biopharmaceutical Details
    • 7.5.2 Qingdao Jiulong Biopharmaceutical Major Business
    • 7.5.3 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.5.4 Qingdao Jiulong Biopharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
    • 7.5.6 Qingdao Jiulong Biopharmaceutical Competitive Strengths & Weaknesses
  • 7.6 Dongying Tiandong Pharmaceutical
    • 7.6.1 Dongying Tiandong Pharmaceutical Details
    • 7.6.2 Dongying Tiandong Pharmaceutical Major Business
    • 7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
    • 7.6.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
  • 7.7 Yino Pharma
    • 7.7.1 Yino Pharma Details
    • 7.7.2 Yino Pharma Major Business
    • 7.7.3 Yino Pharma Low Molecular Weight Heparin API Product and Services
    • 7.7.4 Yino Pharma Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Yino Pharma Recent Developments/Updates
    • 7.7.6 Yino Pharma Competitive Strengths & Weaknesses
  • 7.8 Opocrin
    • 7.8.1 Opocrin Details
    • 7.8.2 Opocrin Major Business
    • 7.8.3 Opocrin Low Molecular Weight Heparin API Product and Services
    • 7.8.4 Opocrin Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Opocrin Recent Developments/Updates
    • 7.8.6 Opocrin Competitive Strengths & Weaknesses
  • 7.9 Hebei Changshan
    • 7.9.1 Hebei Changshan Details
    • 7.9.2 Hebei Changshan Major Business
    • 7.9.3 Hebei Changshan Low Molecular Weight Heparin API Product and Services
    • 7.9.4 Hebei Changshan Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 Hebei Changshan Recent Developments/Updates
    • 7.9.6 Hebei Changshan Competitive Strengths & Weaknesses
  • 7.10 Hubei Enoray Biopharmaceutical
    • 7.10.1 Hubei Enoray Biopharmaceutical Details
    • 7.10.2 Hubei Enoray Biopharmaceutical Major Business
    • 7.10.3 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.10.4 Hubei Enoray Biopharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
    • 7.10.6 Hubei Enoray Biopharmaceutical Competitive Strengths & Weaknesses
  • 7.11 Nanjing Nanda Pharmaceutical
    • 7.11.1 Nanjing Nanda Pharmaceutical Details
    • 7.11.2 Nanjing Nanda Pharmaceutical Major Business
    • 7.11.3 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.11.4 Nanjing Nanda Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 Nanjing Nanda Pharmaceutical Recent Developments/Updates
    • 7.11.6 Nanjing Nanda Pharmaceutical Competitive Strengths & Weaknesses
  • 7.12 Cisen Pharmaceutical
    • 7.12.1 Cisen Pharmaceutical Details
    • 7.12.2 Cisen Pharmaceutical Major Business
    • 7.12.3 Cisen Pharmaceutical Low Molecular Weight Heparin API Product and Services
    • 7.12.4 Cisen Pharmaceutical Low Molecular Weight Heparin API Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.12.5 Cisen Pharmaceutical Recent Developments/Updates
    • 7.12.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Low Molecular Weight Heparin API Industry Chain
  • 8.2 Low Molecular Weight Heparin API Upstream Analysis
    • 8.2.1 Low Molecular Weight Heparin API Core Raw Materials
    • 8.2.2 Main Manufacturers of Low Molecular Weight Heparin API Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Low Molecular Weight Heparin API Production Mode
  • 8.6 Low Molecular Weight Heparin API Procurement Model
  • 8.7 Low Molecular Weight Heparin API Industry Sales Model and Sales Channels
    • 8.7.1 Low Molecular Weight Heparin API Sales Model
    • 8.7.2 Low Molecular Weight Heparin API Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Low Molecular Weight Heparin API. Industry analysis & Market Report on Low Molecular Weight Heparin API is a syndicated market report, published as Global Low Molecular Weight Heparin API Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Low Molecular Weight Heparin API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo